Could you provide an overview of what happened in 2020 due to covid and speculate what the lasting impact will be in 2021. Will there be a continued impact of COVID on FDA resources and submission timelines?

2020 was a rough year for FDA with submissions and reviewers because they have been slammed with EUA requests and the extra product load that was very unexpected because of COVID-19. However, if you look at the MDUFA report, they have been meeting a lot of their goals.

We are passionate about your success. Tell us more about your regulatory and quality needs so we can help.

Book a Consultation

GLOBAL BOTTOM CTA INSTRUCTIONS:

To display custom copy instead of global copy in this section, please go to Show Global Content for Bottom CTA? toggle in the "Contents" tab to the left, toggle it off, save, and then REFRESH the page editor, the custom text will then show up and ready to be edited.

Turning the global content back on will be the same process, go to the toggle and toggle it back on, save and refresh!